Strategies Wealth Advisors, LLC Astrazeneca PLC Transaction History
Strategies Wealth Advisors, LLC
- $916 Billion
- Q2 2025
A detailed history of Strategies Wealth Advisors, LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Strategies Wealth Advisors, LLC holds 3,084 shares of AZN stock, worth $232,348. This represents 0.02% of its overall portfolio holdings.
Number of Shares
3,084
Previous 3,062
0.72%
Holding current value
$232,348
Previous $225 Million
4.24%
% of portfolio
0.02%
Previous 0.03%
Shares
2 transactions
Others Institutions Holding AZN
# of Institutions
1,417Shares Held
510MCall Options Held
9.82MPut Options Held
3.14M-
Price T Rowe Associates Inc Baltimore, MD57.1MShares$4.3 Billion0.52% of portfolio
-
Primecap Management CO Pasadena, CA41.2MShares$3.1 Billion2.35% of portfolio
-
Wellington Management Group LLP Boston, MA35.6MShares$2.68 Billion0.52% of portfolio
-
Bank Of America Corp Charlotte, NC31.8MShares$2.4 Billion0.19% of portfolio
-
Capital International Investors Los Angeles, CA31.4MShares$2.37 Billion0.39% of portfolio
About ASTRAZENECA PLC
- Ticker AZN
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 3,099,020,032
- Market Cap $233B
- Description
- AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...